Table 2.
Serial change in HbA1c (%) during the study period
| Time point | Empagliflozin (n = 154), % | Insulin (n = 147), % | P value |
|---|---|---|---|
| Baseline | 8.9 ± 1.0 | 9.0 ± 1.4 | NS |
| Month 3 | 7.4 ± 0.5 | 7.8 ± 1.7 | < 0.01 |
| Month 6 | 7.3 ± 0.8 | 7.5 ± 1.5 | < 0.01 |
| Month 12 | 7.4 ± 0.8 | 8.0 ± 1.4 | < 0.01 |
| Month 18 | 7.4 ± 0.9 | 8.0 ± 1.3 | < 0.01 |
| Month 24 | 7.5 ± 1.0 | 7.8 ± 1.2 | NS |
| Month 30 | 7.4 ± 0.9 | 7.8 ± 1.1 | NS |
| Month 36 | 7.4 ± 0.8 | 8.0 ± 1.4 | < 0.05 |
Data are expressed as mean ± (SD). For tests of between-group differences, the paired t-test was performed at each time point. P values are expressed as either < 0.05, < 0.01, or NS (non-significant)